DocGo Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares, a 100.00% decline from fiscal 2024.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 16.56K shares, a 96.78% decline from fiscal 2023.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 514.07K shares, a 69.76% decline from fiscal 2022.
- DocGo Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 1.70M shares, a 37.61% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-11 | 0.00 shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 0.00 shares 10-K · filed 2026-03-16 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | 16.13K shares derived: sum of 4 quarters · filed 2026-03-16 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 16.13K shares derived: sum of 4 quarters · filed 2026-03-16 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | 16.56K shares derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-12-31 | 16.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 16.56K shares 10-K · filed 2026-03-16 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 20.51K shares derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | 430.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 157.98K shares derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-08 | 417.96K shares derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | 20.08K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 514.07K shares 10-K · filed 2026-03-16 |
| 2023-09-30 | 137.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 556.54K shares derived: sum of 4 quarters · filed 2024-02-28 |
| 2023-06-30 | 260.41K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 1.44M shares derived: sum of 4 quarters · filed 2024-02-28 |
| 2023-03-31 | 96.10K shares 10-Q · filed 2023-05-09 | 1.60M shares derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-12-31 | 62.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 1.70M shares 10-K · filed 2024-02-28 |
| 2022-09-30 | 1.02M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | |
| 2022-06-30 | 417.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | |
| 2022-03-31 | 195.15K shares 10-Q · filed 2022-05-10 | |
| 2021-12-31 | 1.24M shares 10-K · filed 2023-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |